To designate the Investigations Building of the Food and Drug Administration located at 466 Fernandez Juncos Avenue in San Juan, Puerto Rico, as the "Andres Toro Building".
Latest Action
Became Public Law No: 109-348.
Official Summary
Official summary has not been imported yet.
GovScope Watchdog™
AI Government Intelligence™This bill, designated as H.R. 5026 during the 109th Congress, officially names the Investigations Building of the Food and Drug Administration (FDA) located at 466 Fernandez Juncos Avenue in San Juan, Puerto Rico, as the "Andres Toro Building." The bill has been signed into law and is now Public Law No: 109-348. The legislation is focused solely on the commemoration and naming of a federal building and does not include additional provisions or policy changes.
H.R. 5026 formally designates an FDA building in San Juan, Puerto Rico, as the "Andres Toro Building," with no further policy or operational impact.
- The bill pertains exclusively to the naming of an FDA building in Puerto Rico.
- It has been enacted into law as Public Law No: 109-348 as of October 13, 2006.
- No additional legislative text or policy changes accompany the naming designation.
['Food and Drug Administration (FDA)', 'Residents and officials in San Juan, Puerto Rico', 'Individuals or entities associated with Andres Toro']
["The bill does not specify any funding or maintenance responsibilities related to the building's renaming.", 'No oversight or enforcement mechanisms are included, as the bill is purely commemorative.', 'Potential costs related to signage or administrative updates are not addressed.']
The bill was introduced and passed during the 109th Congress and reflects a common legislative practice of commemorating individuals by naming federal buildings. It was signed into law without recorded opposition or amendments, indicating a straightforward legislative process focused on recognition rather than policy change.
Hidden impact flags detected: 1
GovScope reviewed 1 policy-risk categories. Hover for a quick definition. Click detected flags for bill-specific details.
['The renaming may increase local recognition or pride associated with the FDA building in San Juan, potentially influencing community engagement.', 'Administrative updates such as signage changes may require minor resource allocation by the FDA or related agencies.']
The bill is straightforward and limited to a commemorative naming without policy or budgetary implications. Transparency considerations focus on ensuring that any costs or administrative responsibilities arising from the renaming are clearly managed by the relevant federal agencies. No additional oversight mechanisms are necessary given the bill's scope.
GovScope Intelligence Roadmap
Future bill intelligence will connect sponsors, committee referrals, related votes, campaign finance, disclosures, and stock trades into one legislative intelligence view.